Welcome to our dedicated page for Enpro SEC filings (Ticker: NPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Enpro Inc. (NYSE: NPO) SEC filings, including current reports on Form 8-K and other documents filed with the U.S. Securities and Exchange Commission. Enpro is an industrial technology company with segments in Sealing Technologies and Advanced Surface Technologies, serving end-markets such as semiconductor, industrial process, commercial vehicle, sustainable power generation, aerospace, food and pharma, photonics, and life sciences.
Enpro’s Form 8-K filings include items such as quarterly earnings announcements under Item 2.02, where the company furnishes press releases detailing segment performance, end-market trends, and non-GAAP metrics like adjusted EBITDA and adjusted diluted earnings per share. Other 8-K filings may address corporate governance matters, such as director decisions regarding reelection under Item 5.02.
Through this filings page, users can follow Enpro’s regulatory disclosures related to its Enpro 3.0 strategy, including references to acquisitions like AlpHa Measurement Solutions and Overlook Industries as they are discussed in connection with results of operations. Filings also reference capital structure actions, such as senior notes offerings and credit facility amendments, which are relevant for understanding Enpro’s financing profile.
Stock Titan’s platform enhances these filings with AI-powered summaries that explain key points from lengthy documents in plain language. Users can quickly see the main themes of Enpro’s quarterly reports, current reports, and other submissions, while still having access to the full text as filed with the SEC. Real-time updates from EDGAR and AI-generated highlights help investors and researchers navigate Enpro’s regulatory history more efficiently.
Enpro Inc. executive Amy Bianchi, EVP and Chief Human Resources Officer, reported receiving a grant of stock options. The award covers 1,488 stock options at an exercise price of $0.00 per share, reflecting a compensatory grant rather than an open-market purchase.
The options will vest in approximately equal thirds on February 23, 2027, February 23, 2028, and February 23, 2029, contingent on continued employment, aligning the executive’s incentives with the company’s longer-term performance.
Enpro Inc. executive Robert Savage McLean, EVP, GC, and CAO, reported two transactions. On February 24, 2026, he sold 2,000 shares of common stock in an open-market sale at $277.50 per share, leaving 29,909 shares held directly.
On February 23, 2026, he received a grant of 2,133 stock options at no cost. According to the footnote, these options vest in approximately equal thirds on February 23, 2027, February 23, 2028, and February 23, 2029, subject to continued employment.
ENPRO Inc. notice of proposed sale of common stock under Form 144. The filing lists restricted stock lapses that create saleable shares: 02/18/2022 594 shares, 02/15/2025 933 shares, and 02/16/2025 473 shares. The filing identifies Charles Schwab & Co., Inc. as a broker/custodian and lists an NYSE reference date of 02/24/2026.
NPO filed a Form 144 notifying a proposed sale of 5,853 common shares through Fidelity Brokerage Services LLC on 02/23/2026 with an aggregate value shown as $1,607,058.21.
The filing lists multiple prior stock awards by date and award size, which appear as background on the holdings; timing and final sale execution are not stated in the excerpt.
Enpro Inc. presents an annual report outlining its industrial technology portfolio, 2025 performance and key risks. Net sales from continuing operations reached $1,143.3 million, up from $1,048.7 million in 2024, with the semiconductor market providing $367.1 million or 32.1% of sales.
The company operates through Sealing Technologies and Advanced Surface Technologies, serving diverse end markets such as aerospace, commercial vehicles, food and biopharmaceuticals, power generation and life sciences. Enpro completed the acquisitions of Overlook and AlpHa in late 2025 for a combined $273.9 million, and previously bought AMI in early 2024 for $209.4 million, all to strengthen sensing and biopharma capabilities.
Backlog totaled $256.7 million at December 31, 2025, modestly above 2024. The report highlights concentration risk in Advanced Surface Technologies, including one customer representing about 24% of consolidated 2025 net sales, along with detailed risk disclosures on cyclicality, supply chains, cybersecurity, AI use, climate regulation and international operations.
Enpro Inc. reported strong underlying growth for 2025 while absorbing a large, non-cash pension charge. Fourth-quarter sales rose to $295.4 million, up 14.3%, with organic sales up 9.9%. Adjusted EBITDA increased 19.2% to $69.4 million, but GAAP results showed a $32.0 million net loss driven by a $67.2 million non-cash settlement loss from terminating the U.S. defined benefit pension plan.
For the full year 2025, sales reached $1.14 billion, up 9.0%, and adjusted EBITDA grew 8.9% to $277.6 million. Adjusted diluted EPS rose to $7.91 from $6.96, while GAAP diluted EPS declined to $1.91 largely due to the pension settlement. Operating cash flow increased to $201.2 million and free cash flow to $153.1 million, supporting $26.2 million of dividends and an eleventh consecutive annual dividend increase.
Management introduced 2026 guidance calling for revenue growth of 8%–12%, adjusted EBITDA of $305–$320 million, and adjusted diluted EPS of $8.50–$9.20, reflecting confidence in demand across Sealing Technologies and Advanced Surface Technologies and the benefits of a strengthened balance sheet.
Enpro Inc.'s President and CEO Eric A. Vaillancourt reported equity award activity and related tax withholding transactions. On 02/16/2026 he acquired 13,418 shares of common stock as a grant at $0.0000 per share, increasing his direct holdings to 54,744 shares.
On 02/15/2026 and 02/16/2026, restricted stock units were exercised into 3,211 and 4,011 common shares, respectively, at no cost. To cover tax liabilities, 1,320 shares and 7,480 shares of common stock were disposed of at $272.63 per share through share withholding, leaving 51,275 shares held directly and 2,997 shares held indirectly via a 401(k) plan.
McLean Robert Savage reported multiple insider transaction types in a Form 4 filing for NPO. The filing lists transactions totaling 6,851 shares at a weighted average price of $272.63 per share. Following the reported transactions, holdings were 32,430 shares.
Enpro Inc. executive Larisa R. Joiner reported multiple equity transactions involving company stock. On 02/15/2026 and 02/16/2026, she exercised restricted stock units into common shares at an exercise price of $0, and some of the resulting shares were withheld at $272.63 per share to cover tax obligations. She also received a grant or award of 854 common shares at no cost. Following these transactions, she directly owned 9,431 shares of Enpro common stock.
Enpro Inc. executive Steven R. Bower, SVP, Controller and CAO, reported multiple equity compensation transactions in Enpro common stock. On 02/15/2026 and 02/16/2026, restricted stock units were exercised into common shares at an exercise price of $0, and new common shares were granted at $0.0000 per share.
To cover tax obligations, Bower disposed of common shares through tax-withholding transactions at $272.63 per share. After these activities, he held 3,651 common shares directly and 6,428 common shares indirectly through an IRA, along with 218 restricted stock units that remain outstanding.